Yilan, Taiwan

Ai-Ling Yeh

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Sinphar Pharmaceutical Co., Ltd., Sinphar Pharmaceutical Co., Ltd. (Dongshan, Taiwan), Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou). Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ai-Ling Yeh. Retrieved from https://idiyas.com/inventor/ai-ling-yeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yilan County, TW (2016 - 2018)
  • Dongshan Township, Yilan County, TW (2021 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ai-Ling Yeh

Introduction

Ai-Ling Yeh is a prominent inventor based in Yilan County, Taiwan. She has made significant contributions to the field of pharmaceuticals, particularly in the areas of muscle protection and pulmonary injury treatment. With a total of 5 patents to her name, her work has the potential to impact many lives positively.

Latest Patents

One of Ai-Ling Yeh's latest patents focuses on the uses of FU-LING extract and tumulosic acid in protecting muscles. This method involves administering an effective amount of FU-LING extract, tumulosic acid, and/or a pharmaceutical acceptable salt of tumulosic acid to protect muscle cells against injury. The invention aims to promote regeneration and repair of muscle, regulate, treat, and delay muscle atrophy, especially due to aging, diseases, and cachexia. It also helps maintain normal muscle physiology and neuromuscular function.

Another significant patent addresses the regulation, prevention, and treatment of pulmonary injury. This method involves administering an effective amount of FU-LING extract, tumulosic acid, dehydrotumulosic acid, dehydrotrametenolic acid, and/or poricoic acid A to subjects in need. This innovative approach aims to mitigate pulmonary injury and related diseases.

Career Highlights

Ai-Ling Yeh has worked with Sinphar Pharmaceutical Co., Ltd., where she has contributed her expertise in pharmaceutical development. Her work at this company has allowed her to focus on innovative solutions for health-related issues.

Collaborations

Ai-Ling has collaborated with notable colleagues, including Chao-Jih Wang and Zwe-Ling Kong. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Ai-Ling Yeh's innovative work in muscle protection and pulmonary injury treatment showcases her dedication to improving health outcomes through her inventions. Her contributions are paving the way for advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…